SARS-CoV-2 3CLpro-IN-16
SARS-CoV-2 3CLpro-IN-16 (Compound 3a) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50: 2.124 μM) . SARS-CoV-2 3CLpro-IN-16 binds to the active site and forms a covalent bond with Cys145 of 3CLpro[1].
Product Specifications
CAS Number
352659-40-6
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-16.html
Solubility
10 mM in DMSO
Smiles
N#CSCC(N1C2=C(CCC3=C1C=CC=C3)C=CC=C2)=O
Molecular Formula
C17H14N2OS
Molecular Weight
294.37
References & Citations
[1]Ren P, et al. Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group. J Med Chem. 2023 Aug 18.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AN301712L-01 50 µL
Recombinant Na+/K+ ATPase alpha-1 Monoclonal Antibody
Sign In for Pricing
View Details AN301712L-02 100 µL
Recombinant Na+/K+ ATPase alpha-1 Monoclonal Antibody
Sign In for Pricing
View Details